Showing 1 - 3 results of 3 for search 'David Liberg', query time: 0.03s
Refine Results
-
1
-
2
Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides. by Per Björk, Anders Björk, Thomas Vogl, Martin Stenström, David Liberg, Anders Olsson, Johannes Roth, Fredrik Ivars, Tomas Leanderson
Published 2009-04-01
Article -
3